Association between chronic osteomyelitis and deep-vein thrombosis

Te-Yu Lin; Yu-Guang Chen; Wen-Yen Huang; Cheng-Li Lin; Chiao-Ling Peng; Fung-Chang Sung; Chia-Hung Kao

doi:10.1160/TH14-01-0012

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2014; 112(03): 573-579
DOI: 10.1160/TH14-01-0012

Wound healing and inflammation/infection

Schattauer GmbH

Association between chronic osteomyelitis and deep-vein thrombosis

Analysis of a nationwide population-based registry

Te-Yu Lin

¹Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

,

Yu-Guang Chen

²Division of Hematology and Oncology, Department of Internal Medicine, National Defense Medical Center, Taipei, Taiwan

,

Wen-Yen Huang

³Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

,

Cheng-Li Lin

⁴Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan

,

Chiao-Ling Peng

⁵Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan

,

Fung-Chang Sung

⁶Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taiwan

,

Chia-Hung Kao

⁶Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taiwan

⁷Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan

› Author Affiliations

Abstract

Summary

Studies on the association between chronic osteomyelitis and deep vein thrombosis (DVT) and pulmonary thromboembolism (PE) are scarce. The aim of this study was to analyse a nationwide population-based database for association between DVT or PE after a diagnosis of chronic osteomyelitis. This nationwide population-based cohort study was based on data obtained from the Taiwan National Health Insurance Database from 1998 to 2008, with a follow-up period extending to the end of 2010. We identified patients with chronic osteomyelitis using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. The patients with chronic osteomyelitis and comparison controls were selected by 1:1 matching on a propensity score. The propensity score was calculated by a logistic regression to estimate the probability of the treatment assignment given the baseline variables including age, sex, and Charlson comorbidity index score. We analysed the risks of DVT and PE by using Cox proportional hazards regression models, including sex, age, and comorbidities. In total, 24,335 chronic osteomyelitis patients and 24,335 controls were enrolled in the study. The risk of developing DVT was 2.49-fold in patients with chronic osteomyelitis compared with the comparison cohort, after adjusting for age, sex, and comorbidities. The multiplicative increased risks of DVT were also significant in patients with chronic osteomyelitis with any comorbidity. In conclusion, physicians should consider chronic osteomyelitis in their evaluation of risk factors for DVT.

Keywords

Chronic osteomyelitis - deep vein thrombosis - pulmonary embolism

Full Text

References

References
1 Calhoun JH, Manring MM. Adult osteomyelitis. Infect Dis Clin N Am 2005; 19: 756-786.
2 Spellberg B, Lipsky BA. Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infect Dis 2012; 54: 393-407.
3 Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet 2012; 379: 1835-1846.
4 Cohen AT. et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371: 387-94.
5 Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost 2005; 03: 1611-1617.
6 Alikhan R. et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 2004; 164: 963-968.
7 Kahn SR. et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e195S-226S.
8 Rogers MAM. et al. Triggers of hospitalisation for venous thromboembolism. Circulation 2012; 125: 2092-2099.
9 Schmidt M. et al. Acute infections and venous thromboembolism. J Intern Med 2012; 271: 608-618.
10 Bureau of National Health Insurance, Department of Health. Bureau of National Health Insurance. Department of Health. Taiwan: [cited September 2010] http://www.nhi.gov.tw/webdata/AttachFiles/Attach_14258_2_97-ch.pdf
11 Chung WS. et al. Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann Rheum Dis. 2013 Epub ahead of print.
12 Liang JA. et al. Malignancies associated with systemic lupus erythematosus in Taiwan: a nationwide population-based cohort study. Rheumatol Int 2012; 32: 773-778.
13 Cheng CL. et al. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011; 20: 236-242.
14 Dong YH. et al. Development and validation of a pharmacy-based comorbidity measure in a population-based automated health care database. Pharmacotherapy 2013; 33: 126-136.
15 Smeeth L. et al. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006; 367: 1075-1079.
16 Bouchoucha S. et al. Deep venous thrombosis associated with acute hematogenous osteomyelitis in children. Orthop Traumatol Surg Res 2010; 96: 890-893.
17 Hollmig ST. et al. Deep venous thrombosis associated with osteomyelitis in children. J Bone Joint Surg Am 2007; 89: 1517-1523.
18 Levi M. et al. Sepsis and Thrombosis. Semin. Thromb. Hemost. 2013; 39: 559-566.
19 Downing LJ. et al. Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation. ASAIO J 1996; 42: M677-682.
20 Wakefield TW. et al. P-selectin and TNF inhibition reduce venous thrombosis inflammation. J Surg Res 1996; 64: 26-31.
21 Downing LJ. et al. IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. J Immunol 1998; 161: 1471-1476.
22 Henke PK. et al. Viral IL-10 gene transfer decreases inflammation and cell adhesion molecule expression in a rat model of venous thrombosis. J Immunol 2000; 164: 2131-2141.
23 Downing LJ. et al. Anti-Pselectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 1997; 25: 816-827.
24 Wakefield TW. et al. Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy. J Vasc Surg 2000; 31: 309-324.
25 Myers Jr, DD. et al. P-Selectin antagonism causes dose-dependent venous thrombosis inhibition. Thromb. Haemost 2001; 85: 423-429.
26 Myers D. et al. New and effective treatment of experimentally induced venous thrombosis with anti-inflammatory rPSGL-Ig. Thromb. Haemost 2002; 87: 374-382.
27 Myers Jr, DD. et al. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. J Surg Res 2002; 108: 212-221.
28 Silverstein MD. et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158: 585-593.
29 Folsom AR. et al. Frailty and risk of venous thromboembolism in older adults. J Gerontol A Biol Sci Med Sci 2007; 62: 79-82.
30 Kanapuru B, Ershler WB. Inflammation, coagulation, and the pathway to frailty. Am J Med 2009; 122: 605-613.
31 Kuppalli K. et al. Lemierre’s syndrome due to Fusobacterium necrophorum. Lancet Infect Dis 2012; 12: 808-815.